VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From
Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45

Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45

Warning: mktime(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45

Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45
Oct 01, 2017 To
Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45
Oct 23, 2017:


Bacillus anthracis (Anthrax)

  1. Kracalik IT, Kenu E, Ayamdooh EN, Allegye-Cudjoe E, Polkuu PN, Frimpong JA, Nyarko KM, Bower WA, Traxler R, Blackburn JK. Modeling the environmental suitability of anthrax in Ghana and estimating populations at risk: Implications for vaccination and control PLoS neglected tropical diseases 11(10):e0005885 2017 [PMID: 29028799]
  2. Kracalik I, Malania L, Broladze M, Navdarashvili A, Imnadze P, Ryan SJ, Blackburn JK. Changing livestock vaccination policy alters the epidemiology of human anthrax, Georgia, 2000-2013 Vaccine 2017 [PMID: 28988866]
  3. O'Leary ST, Kimberlin DW. Update From the Advisory Committee on Immunization Practices Journal of the Pediatric Infectious Diseases Society 2017 [PMID: 29036392]
  4. Banerjee D, Chakraborty B, Chakraborty B. Anthrax: Where Margins are Merging between Emerging Threats and Bioterrorism Indian journal of dermatology 62(5):456-458 2017 [PMID: 28979006]

Brucella (Brucellosis)

  1. Junqueira Junior DG, Lima AMC, Rosinha GMS, Carvalho CEG, Oliveira CE, Sanches CC. Detection of Brucella abortus B19 strain DNA in seminal plasma by polymerase chain reaction in Brazil Transboundary and emerging diseases 2017 [PMID: 29034582]
  2. Higgins JL, Gonzalez-Juarrero M, Bowen RA. Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1 PloS one 12(10):e0185823 2017 [PMID: 29028813]
  3. Mailybayeva A, Yespembetov B, Ryskeldinova S, Zinina N, Sansyzbay A, Renukaradhya GJ, Petrovsky N, Tabynov K. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats PloS one 12(10):e0186484 2017 [PMID: 29023541]
  4. Zhao Y, Hanniffy S, Arce-Gorvel V, Conde-Alvarez R, Oh S, Moriyón I, Mémet S, Gorvel JP. Immunomodulatory properties of Brucella melitensis lipopolysaccharide determinants on mouse dendritic cells in vitro and in vivo Virulence :0 2017 [PMID: 28968180]

Burkholderia mallei (Glanders)

  1. Bayliss M, Donaldson MI, Nepogodiev SA, Pergolizzi G, Scott AE, Harmer NJ, Field RA, Prior JL. Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection Carbohydrate research 452:17-24 2017 [PMID: 29024844]

Burkholderia pseudomallei (Melioidosis)

  1. Bayliss M, Donaldson MI, Nepogodiev SA, Pergolizzi G, Scott AE, Harmer NJ, Field RA, Prior JL. Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection Carbohydrate research 452:17-24 2017 [PMID: 29024844]

Ebola virus

  1. Suschak JJ, Schmaljohn CS. Future Approaches to DNA Vaccination Against Hemorrhagic Fever Viruses Methods in molecular biology (Clifton, N.J.) 1604:339-348 2018 [PMID: 28986847]
  2. Gonzalez-Quintial R, Baccala R. Murine Models for Viral Hemorrhagic Fever Methods in molecular biology (Clifton, N.J.) 1604:257-267 2018 [PMID: 28986841]
  3. Gonzalez JP, Souris M, Valdivia-Granda W. Global Spread of Hemorrhagic Fever Viruses: Predicting Pandemics Methods in molecular biology (Clifton, N.J.) 1604:3-31 2018 [PMID: 28986822]
  4. Kennedy SB, Bolay F, Kieh M, Grandits G, Badio M, Ballou R, Eckes R, Feinberg M, Follmann D, Grund B, Gupta S, Hensley L, Higgs E, Janosko K, Johnson M, Kateh F, Logue J, Marchand J, Monath T, Nason M, Nyenswah T, Roman F, Stavale E, Wolfson J, Neaton JD, Lane HC. Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia The New England journal of medicine 377(15):1438-1447 2017 [PMID: 29020589]
  5. Schafer AM, Cheng H, Lee C, Du R, Han J, Perez J, Peet N, Manicassamy B, Rong L. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Current medicinal chemistry 2017 [PMID: 29032747]
  6. Gsell PS, Camacho A, Kucharski AJ, Watson CH, Bagayoko A, Danmadji S, Dean NE, Diallo A, Diallo A, Djidonou H, Doumbia M, Enwere G, Higgs ES, Mauget T, Mory D, Riveros X, Oumar FT, Toure A, Vicari AS, Longini IM, Edmunds WJ, Henao-Restrepo AM, Kieny MP, Kéïta S. Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report The Lancet. Infectious diseases 2017 [PMID: 29033032]
  7. Agnandji ST, Fernandes JF, Bache EB, Obiang Mba RM, Brosnahan JS, Kabwende L, Pitzinger P, Staarink P, Massinga-Loembe M, Krähling V, Biedenkopf N, Fehling SK, Strecker T, Clark DJ, Staines HM, Hooper JW, Silvera P, Moorthy V, Kieny MP, Adegnika AA, Grobusch MP, Becker S, Ramharter M, Mordmüller B, Lell B, Krishna S, Kremsner PG. Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial PLoS medicine 14(10):e1002402 2017 [PMID: 28985239]
  8. Dutta P, Halder AK, Basu S, Kundu M. A survey on Ebola genome and current trends in computational research on the Ebola virus Briefings in functional genomics 2017 [PMID: 28968729]

Escherichia coli

  1. Gomes-Solecki M, Richer L. Recombinant E. coli Dualistic Role as an Antigen-adjuvant Delivery Vehicle for Oral Immunization Methods in molecular biology (Clifton, N.J.) 1690:347-357 2018 [PMID: 29032558]
  2. Andersson ME, Elfving K, Shakely D, Nilsson S, Msellem M, Trollfors B, Mårtensson A, Björkman A, Lindh M. Rapid Clearance and Frequent Reinfection With Enteric Pathogens Among Children With Acute Diarrhea in Zanzibar Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 65(8):1371-1377 2017 [PMID: 29017253]
  3. Visagan R, Livermore LJ, Kelly D, Magdum S. Subclinical meningoventriculitis as a cause of obstructive hydrocephalus BMJ case reports 2017 2017 [PMID: 29025781]
  4. Longet S, Aversa V, O'Donnell D, Tobias J, Rosa M, Holmgren J, Coulter IS, Lavelle EC. Thermostability of the coating, antigen and immunostimulator in an adjuvanted oral capsule vaccine formulation International journal of pharmaceutics 534(1-2):60-70 2017 [PMID: 29024788]
  5. Gong W, Xiong X, Wang P, Jiao J, Yang X, Wen B. Th1 epitope peptides induce protective immunity against Rickettsia rickettsii infection in C3H/HeN mice Vaccine 2017 [PMID: 29032899]
  6. Powell EC, Mahajan PV, Roosevelt G, Hoyle JD Jr, Gattu R, Cruz AT, Rogers AJ, Atabaki SM, Jaffe DM, Casper TC, Ramilo O, Kuppermann N. Epidemiology of Bacteremia in Febrile Infants Aged 60 Days and Younger Annals of emergency medicine 2017 [PMID: 28988964]
  7. Walker RI, Wierzba TF, Mani S, Bourgeois AL. Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference Vaccine 2017 [PMID: 28987444]
  8. Abbanat D, Davies TA, Amsler K, He W, Fae K, Janssen S, Poolman JT, van den Dobbelsteen GPJM. Development and qualification of an opsonophagocytic killing assay to assess immunogenicity of a bioconjugated <i>Escherichia coli</i> vaccine Clinical and vaccine immunology : CVI 2017 [PMID: 28971965]
  9. Maeda DLNF, Batista MT, Pereira LR, de Jesus Cintra M, Amorim JH, Mathias-Santos C, Pereira SA, Boscardin SB, Silva SDR, Faquim-Mauro EL, Silveira VB, Oliveira DBL, Johnston SA, Ferreira LCS, Rodrigues JF. Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein Frontiers in immunology 8:1175 2017 [PMID: 28993770]
  10. Wang S, Huang W, Li K, Yao Y, Yang X, Bai H, Sun W, Liu C, Ma Y. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor International journal of nanomedicine 12:6813-6825 2017 [PMID: 28979120]

Francisella tularensis (Tularemia)

  1. Post DMB, Slütter B, Schilling B, Chande AT, Rasmussen JA, Jones BD, D'Souza AK, Reinders LM, Harty JT, Gibson BW, Apicella MA. Characterization of Inner and Outer Membrane Proteins from <i>Francisella tularensis</i> Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates mBio 8(5) 2017 [PMID: 29018123]
  2. Nguyen JQ, Zogaj X, Adelani AA, Chu P, Yu JJ, Arulanandam BP, Klose KE. Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis Journal of visualized experiments : JoVE (127) 2017 [PMID: 28994770]

Hantavirus

  1. Gonzalez JP, Souris M, Valdivia-Granda W. Global Spread of Hemorrhagic Fever Viruses: Predicting Pandemics Methods in molecular biology (Clifton, N.J.) 1604:3-31 2018 [PMID: 28986822]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N, Bell-Mandla N, Smith PC, Floyd S, Bock P, Ayles H, Beyers N, Donnell D, Fidler S, Hayes R, Hauck K. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial The Lancet. Global health 5(11):e1133-e1141 2017 [PMID: 28964756]
  2. Sun P, Crum-Cianflone NF, Defang G, Williams M, Ganesan A, Agan BK, Lalani T, Whitman T, Brandt C, Burgess TH. Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals Vaccine 35(45):6103-6111 2017 [PMID: 28987439]
  3. Huot N, Jacquelin B, Garcia-Tellez T, Rascle P, Ploquin MJ, Madec Y, Reeves RK, Derreudre-Bosquet N, Müller-Trutwin M. Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys Nature medicine 2017 [PMID: 29035370]
  4. Lee YL, Lin KY, Cheng CY, Li CW, Yang CJ, Tsai MS, Tang HJ, Lin TY, Wang NC, Lee YC, Lin SP, Huang YS, Sun HY, Zhang JY, Ko WC, Cheng SH, Lee YT, Liu CE, Hung CC. Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan PloS one 12(10):e0186338 2017 [PMID: 29036227]
  5. Adu-Gyamfi CG, Snyman T, Hoffmann CJ, Martinson NA, Chaisson RE, George JA, Suchard MS. Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 65(8):1356-1358 2017 [PMID: 29017244]
  6. Williams WB, Han Q, Haynes BF. Cross-reactivity of HIV vaccine responses and the microbiome Current opinion in HIV and AIDS 2017 [PMID: 29035947]
  7. Gama L, Koup RA. New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment Annual review of medicine 2017 [PMID: 29029583]
  8. Poljak M, Šterbenc A, Lunar MM. Prevention of human papillomavirus (HPV) - related tumors in people living with human immunodeficiency virus (HIV) Expert review of anti-infective therapy 2017 [PMID: 29027811]
  9. Lian XD, Zhang XH, Dai ZX, Zheng YT. Identification of the major histocompatibility complex class-II DM and DO alleles in a cohort of northern pig-tailed macaques (Macaca leonina) Immunogenetics 2017 [PMID: 29030661]
  10. Dragon CN, Laffan AM, Erdem E, Cahill S, Kenefick D, Ye J, Haffer SC. Health Indicators for Older Sexual Minorities: National Health Interview Survey, 2013-2014 LGBT health 2017 [PMID: 29028455]
  11. Qadir MI. Hepatitis in AIDS patients Reviews in medical virology 2017 [PMID: 29027728]
  12. Sanders EJ, Price MA, Karita E, Kamali A, Kilembe W, Bekker LG, Lakhi S, Inambao M, Anzala O, Fast PE, Gilmour J, Powers KA. Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa AIDS (London, England) 2017 [PMID: 29028659]
  13. Rocha C, Duarte J, Borrego P, Calado R, Marcelino JM, Tendeiro R, Valadas E, Sousa AE, Taveira N. Potency of HIV-2-specific antibodies increase in direct association with loss of memory B-cells AIDS (London, England) 2017 [PMID: 29028655]
  14. Peeling RW, Mabey D, Kamb ML, Chen XS, Radolf JD, Benzaken AS. Syphilis Nature reviews. Disease primers 3:17073 2017 [PMID: 29022569]
  15. Barouch DH, Picker LJ. Novel vaccine vectors for HIV-1 Nature reviews. Microbiology 15(11):696 2017 [PMID: 29021601]
  16. Kiwuwa-Muyingo S, Nazziwa J, Ssemwanga D, Ilmonen P, Njai H, Ndembi N, Parry C, Kitandwe PK, Gershim A, Mpendo J, Neilsen L, Seeley J, Seppälä H, Lyagoba F, Kamali A, Kaleebu P. HIV-1 transmission networks in high risk fishing communities on the shores of Lake Victoria in Uganda: A phylogenetic and epidemiological approach PloS one 12(10):e0185818 2017 [PMID: 29023474]
  17. McGrath CJ, Garcia R, Trinh TT, Richardson BA, John-Stewart GC, Nyongesa-Malava E, Mugo NR, Glynn EH, Sakr SR, De Vuyst H, Chung MH. Role of p16 testing in cervical cancer screening among HIV-infected women PloS one 12(10):e0185597 2017 [PMID: 29023464]
  18. Haidari G, Cope A, Miller A, Venables S, Yan C, Ridgers H, Reijonen K, Hannaman D, Spentzou A, Hayes P, Bouliotis G, Vogt A, Joseph S, Combadiere B, McCormack S, Shattock RJ. Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial Scientific reports 7(1):13011 2017 [PMID: 29026141]
  19. Izurieta HS, Moro PL, Chen RT. Hospital-based collaboration for epidemiological investigation of vaccine safety: A potential solution for low and middle-income countries? Vaccine 2017 [PMID: 29033065]
  20. McGuire EP, Fong Y, Toote C, Cunningham CK, McFarland EJ, Borkowsky W, Barnett S, Itell HL, Kumar A, Gray G, McElrath MJ, Tomaras GD, Permar SR, Fouda GG. HIV exposed infants vaccinated with a MF59/rgp120 vaccine have higher magnitude anti-V1V2 IgG responses than adults immunized with the same vaccine Journal of virology 2017 [PMID: 29021402]
  21. Shen X, Basu R, Sawant S, Beaumont D, Kwa SF, LaBranche C, Seaton KE, Yates NL, Montefiori DC, Ferrari G, Wyatt LS, Moss B, Alam SM, Haynes BF, Tomaras GD, Robinson HL. HIV-1 gp120 Protein and MVAgp140 Boost Immunogens Increase immunogenicity of a DNA/MVA HIV-1 Vaccine Journal of virology 2017 [PMID: 29021394]
  22. Leitman EM, Palmer CD, Buus S, Chen F, Riddell L, Sims S, Klenerman P, Sáez-Cirión A, Walker BD, Hess PR, Altfeld M, Matthews PC, Goulder PJR. Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificities PloS one 12(10):e0184496 2017 [PMID: 29020090]
  23. McCurley NP, Domi A, Basu R, Saunders KO, LaBranche CC, Montefiori DC, Haynes BF, Robinson HL. HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site PloS one 12(10):e0177863 2017 [PMID: 29020058]
  24. Wu J, Zhao C, Liu Q, Huang W, Wang Y. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system Vaccine 2017 [PMID: 29031692]
  25. Jantarabenjakul W, Anugulruengkitt S, Kasipong N, Thammajaruk N, Sophonphan J, Bunupuradah T, Cressey TR, Colbers A, Burger DM, Phongsamart W, Puthanakit T, Pancharoen C. Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically-suppressed HIV-1-infected adolescents Antiviral therapy 2017 [PMID: 28994660]
  26. Martins-Fonteyn E, Loquiha O, Baltazar C, Thapa S, Boothe M, Raimundo I, Hens N, Aerts M, Meulemans H, Degomme O, Wouters E. Factors influencing risky sexual behaviour among Mozambican miners: a socio-epidemiological contribution for HIV prevention framework in Mozambique International journal for equity in health 16(1):179 2017 [PMID: 29017564]
  27. Tiam A, Gill MM, Hoffman HJ, Isavwa A, Mokone M, Foso M, Safrit JT, Mofenson LM, Tylleskär T, Guay L. Conventional early infant diagnosis in Lesotho from specimen collection to results usage to manage patients: Where are the bottlenecks? PloS one 12(10):e0184769 2017 [PMID: 29016634]
  28. Liu D, Wang C, Hora B, Zuo T, Goonetilleke N, Liu MKP, Berrong M, Ferrari G, McMichael AJ, Bhattacharya T, Perelson AS, Gao F. A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies Retrovirology 14(1):46 2017 [PMID: 29017536]
  29. Ana-Sosa-Batiz F, Johnston APR, Hogarth PM, Wines BD, Barr I, Wheatley AK, Kent SJ. Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults Vaccine 2017 [PMID: 29029940]
  30. Mukhopadhyay M, Galperin M, Patgaonkar M, Vasan S, Ho DD, Nouël A, Claireaux M, Benati D, Lambotte O, Huang Y, Chakrabarti LA. DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers Journal of immunology (Baltimore, Md. : 1950) 2017 [PMID: 28993513]
  31. Semá Baltazar C, Langa JP, Dengo Baloi L, Wood R, Ouedraogo I, Njanpop-Lafourcade BM, Inguane D, Elias Chitio J, Mhlanga T, Gujral L, D Gessner B, Munier A, A Mengel M. Multi-site cholera surveillance within the African Cholera Surveillance Network shows endemicity in Mozambique, 2011-2015 PLoS neglected tropical diseases 11(10):e0005941 2017 [PMID: 28991895]
  32. Koen J, Wassenaar D, Mamotte N. The 'over-researched community': An ethics analysis of stakeholder views at two South African HIV prevention research sites Social science & medicine (1982) 194:1-9 2017 [PMID: 29035778]
  33. Karlsson I, Borggren M, Jensen SS, Heyndrickx L, Stewart-Jones G, Scarlatti G, Fomsgaard A. Immunization with clinical HIV-1 Env proteins induces broad antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies in a rabbit vaccination model AIDS research and human retroviruses 2017 [PMID: 28982260]
  34. Beg S, Gaur P, Mishra S. New Drugs And Vaccines For Tuberculosis Recent patents on anti-infective drug discovery 2017 [PMID: 28990539]
  35. Cohen MS, Corey L. Broadly neutralizing antibodies to prevent HIV-1 Science (New York, N.Y.) 358(6359):46-47 2017 [PMID: 28983040]
  36. Mall AS, Habte H, Mthembu Y, Peacocke J, de Beer C. Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus? Virology journal 14(1):192 2017 [PMID: 28985745]
  37. Li H, Nykoluk M, Li L, Liu LR, Omange RW, Soule G, Schroeder LT, Toledo N, Kashem MA, Correia-Pinto JF, Liang B, Schultz-Darken N, Alonso MJ, Whitney JB, Plummer FA, Luo M. Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques PloS one 12(10):e0186079 2017 [PMID: 28982126]
  38. Gift SK, Leaman DP, Zhang L, Kim AS, Zwick MB. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex Journal of virology 2017 [PMID: 28978711]
  39. Aberra H, Gordien E, Desalegn H, Berhe N, Medhin G, Mekasha B, Gundersen SG, Gerber A, Stene-Johansen K, Øverbø J, Johannessen A. Hepatitis delta virus infection in a large cohort of chronic hepatitis B patients in Ethiopia Liver international : official journal of the International Association for the Study of the Liver 2017 [PMID: 28980394]
  40. Mayr LM, Decoville T, Schmidt S, Laumond G, Klingler J, Ducloy C, Bahram S, Zolla-Pazner S, Moog C. Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity Scientific reports 7(1):12655 2017 [PMID: 28978939]
  41. Chen J, Ren R, Yu F, Wang C, Zhang X, Li W, Tan S, Jiang S, Liu S, Li L. A Degraded Fragment of HIV-1 Gp120 in Rat Hepatocytes Forms Fibrils and Enhances HIV-1 Infection Biophysical journal 113(7):1425-1439 2017 [PMID: 28978437]
  42. Sher G, Zhi D, Zhang S. DRREP: deep ridge regressed epitope predictor BMC genomics 18(Suppl 6):676 2017 [PMID: 28984193]
  43. Voss JE, Andrabi R, McCoy LE, de Val N, Fuller RP, Messmer T, Su CY, Sok D, Khan SN, Garces F, Pritchard LK, Wyatt RT, Ward AB, Crispin M, Wilson IA, Burton DR. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model Cell reports 21(1):222-235 2017 [PMID: 28978475]
  44. Root-Bernstein R. Human Immunodeficiency Virus Proteins Mimic Human T Cell Receptors Inducing Cross-Reactive Antibodies International journal of molecular sciences 18(10) 2017 [PMID: 28972547]
  45. Viegas EO, Tembe N, Nilsson C, Meggi B, Maueia C, Augusto O, Stout R, Scarlatti G, Ferrari G, Earl P, Wahren B, Andersson S, Robb M, Osman N, Biberfeld G, Jani I, Sandström E. Intradermal HIV-1 DNA immunization using needle-free Zetajet&lt;sup&gt;TM&lt;/sup&gt; injection followed by HIV-modified vaccinia virus Ankara vaccination is safe and immunogenic in Mozambican young adults: a phase I randomized controlled trial AIDS research and human retroviruses 2017 [PMID: 28969431]
  46. Estes JD, Kityo C, Ssali F, Swainson L, Makamdop KN, Del Prete GQ, Deeks SG, Luciw PA, Chipman JG, Beilman GJ, Hoskuldsson T, Khoruts A, Anderson J, Deleage C, Jasurda J, Schmidt TE, Hafertepe M, Callisto SP, Pearson H, Reimann T, Schuster J, Schoephoerster J, Southern P, Perkey K, Shang L, Wietgrefe SW, Fletcher CV, Lifson JD, Douek DC, McCune JM, Haase AT, Schacker TW. Defining total-body AIDS-virus burden with implications for curative strategies Nature medicine 2017 [PMID: 28967921]
  47. Gristick HB, Wang H, Bjorkman PJ. X-ray and EM structures of a natively glycosylated HIV-1 envelope trimer Acta crystallographica. Section D, Structural biology 73(Pt 10):822-828 2017 [PMID: 28994411]
  48. Cossarizza A, Chang HD, Radbruch A, Andrä I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, Baumgart S, Becher B, Beisker W, Berek C, Blanco A, Borsellino G, Boulais PE, Brinkman RR, Büscher M, Busch DH, Bushnell TP, Cao X, Cavani A, Chattopadhyay PK, Cheng Q, Chow S, Clerici M, Cooke A, Cosma A, Cosmi L, Cumano A, Dang VD, Davies D, De Biasi S, Del Zotto G, Della Bella S, Dellabona P, Deniz G, Dessing M, Diefenbach A, Di Santo J, Dieli F, Dolf A, Donnenberg VS, Dörner T, Ehrhardt GRA, Endl E, Engel P, Engelhardt B, Esser C, Everts B, Falk CS, Fehniger TA, Filby A, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frenette PS, Galbraith D, Garbi N, García-Godoy MD, Ghoreschi K, Gibellini L, Goettlinger C, Goodyear CS, Gori A, Grogan J, Gross M, Grützkau A, Grummitt D, Hahn J, Hammer Q, Hauser AE, Haviland DL, Hedley D, Herrera G, Herrmann M, Hiepe F, Holland T, Hombrink P, Houston JP, Hoyer BF, Huang B, Hunter CA, Iannone A, Jäck HM, Jávega B, Jonjic S, Juelke K, Jung S, Kaiser T, Kalina T, Keller B, Khan S, Kienhöfer D, Kroneis T, Kunkel D, Kurts C, Kvistborg P, Lannigan J, Lantz O, Larbi A, LeibundGut-Landmann S, Leipold MD, Levings MK, Litwin V, Liu Y, Lohoff M, Lombardi G, Lopez L, Lovett-Racke A, Lubberts E, Ludewig B, Lugli E, Maecker HT, Martrus G, Matarese G, Maueröder C, McGrath M, McInnes I, Mei HE, Melchers F, Melzer S, Mielenz D, Mills K, Mjösberg J, Moore J, Moran B, Moretta A, Moretta L, Mosmann TR, Müller S, Müller W, Münz C, Multhoff G, Munoz LE, Murphy KM, Nakayama T, Nasi M, Neudörfl C, Nolan J, Nourshargh S, O'Connor JE, Ouyang W, Oxenius A, Palankar R, Panse I, Peterson P, Peth C, Petriz J, Philips D, Pickl W, Piconese S, Pinti M, Pockley AG, Podolska MJ, Pucillo C, Quataert SA, Radstake TRDJ, Rajwa B, Rebhahn JA, Recktenwald D, Remmerswaal EBM, Rezvani K, Rico LG, Robinson JP, Romagnani C, Rubartelli A, Ruland J, Sakaguchi S, Sala-de-Oyanguren F, Samstag Y, Sanderson S, Sawitzki B, Scheffold A, Schiemann M, Schildberg F, Schimisky E, Schmid SA, Schmitt S, Schober K, Schüler T, Schulz AR, Schumacher T, Scotta C, Shankey TV, Shemer A, Simon AK, Spidlen J, Stall AM, Stark R, Stehle C, Stein M, Steinmetz T, Stockinger H, Takahama Y, Tarnok A, Tian Z, Toldi G, Tornack J, Traggiai E, Trotter J, Ulrich H, van der Braber M, van Lier RAW, Veldhoen M, Vento-Asturias S, Vieira P, Voehringer D, Volk HD, von Volkmann K, Waisman A, Walker R, Ward MD, Warnatz K, Warth S, Watson JV, Watzl C, Wegener L, Wiedemann A, Wienands J, Willimsky G, Wing J, Wurst P, Yu L, Yue A, Zhang Q, Zhao Y, Ziegler S, Zimmermann J. Guidelines for the use of flow cytometry and cell sorting in immunological studies European journal of immunology 47(10):1584-1797 2017 [PMID: 29023707]
  49. Rouers A, Jeger-Madiot R, Moris A, Graff-Dubois S. [Follicular helper T cells and HIV - United for better and worse] Medecine sciences : M/S 33(10):878-886 2017 [PMID: 28994384]
  50. Li M, Li R, Shen Z, Li C, Liang N, Peng Z, Huang W, He C, Zhong F, Tang X, Lan G. Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program BMC public health 17(1):759 2017 [PMID: 28962612]
  51. Haban H, Benchekroun S, Sadeq M, Benjouad A, Amzazi S, Oumzil H, Elharti E. Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco BMC public health 17(1):752 2017 [PMID: 28962610]
  52. Okoye IS, Houghton M, Tyrrell L, Barakat K, Elahi S. Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8<sup>+</sup> T Cell Responses to Chronic Viral Infections and Cancer Frontiers in immunology 8:1215 2017 [PMID: 29033936]
  53. Nogal B, Bowman CA, Ward AB. Time-course, negative-stain electron microscopy-based analysis for investigating protein-protein interactions at the single-molecule level The Journal of biological chemistry 2017 [PMID: 28972148]
  54. Dong KL, Moodley A, Kwon DS, Ghebremichael MS, Dong M, Ismail N, Ndhlovu ZM, Mabuka JM, Muema DM, Pretorius K, Lin N, Walker BD, Ndung'u T. Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study The lancet. HIV 2017 [PMID: 28978417]
  55. Nemes E, Hesseling AC, Tameris M, Mauff K, Downing K, Mulenga H, Rose P, van der Zalm M, Mbaba S, Van As D, Hanekom WA, Walzl G, Scriba TJ, McShane H, Hatherill M. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 [PMID: 29028973]
  56. Nonzee NJ, Baldwin SB, Cui Y, Singhal R. Disparities in parental human papillomavirus (HPV) vaccine awareness and uptake among adolescents Vaccine 2017 [PMID: 28967520]
  57. Drury RE, O'Connor D, Pollard AJ. The Clinical Application of MicroRNAs in Infectious Disease Frontiers in immunology 8:1182 2017 [PMID: 28993774]
  58. Yu T, Wu L, Gilbert PB. A joint model for mixed and truncated longitudinal data and survival data, with application to HIV vaccine studies Biostatistics (Oxford, England) 2017 [PMID: 29028943]
  59. Wamamba D, Onyango D, Oyugi E, Kanyina E, Obonyo M, Githuku J, Ransom J. Transfusion Transmissible Infections Among Walk-In Blood Donors at Kisumu Regional Blood Transfusion Centre, Kisumu County, Kenya, 2015 Laboratory medicine 2017 [PMID: 29036415]
  60. Huang Y, Pantaleo G, Tapia G, Sanchez B, Zhang L, Trondsen M, Hovden AO, Pollard R, Rockstroh J, Ökvist M, Sommerfelt MA. Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial EBioMedicine 2017 [PMID: 28970080]
  61. Nieuwenhuizen NE, Kulkarni PS, Shaligram U, Cotton MF, Rentsch CA, Eisele B, Grode L, Kaufmann SHE. The Recombinant Bacille Calmette-Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing Frontiers in immunology 8:1147 2017 [PMID: 28974949]
  62. Molinos-Albert LM, Clotet B, Blanco J, Carrillo J. Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target Frontiers in immunology 8:1154 2017 [PMID: 28970835]
  63. McLaren PJ, Pulit SL, Gurdasani D, Bartha I, Shea PR, Pomilla C, Gupta N, Gkrania-Klotsas E, Young EH, Bannert N, Amo JD, Gill J, Gilmour J, Kellam P, Kelleher AD, Sönnerborg A, Zangerle R, Post FA, Fisher M, Haas DW, Walker BD, Porter K, Goldstein DB, Sandhu MS, de Bakker PIW, Fellay J. Evaluating the impact of functional genetic variation on HIV-1 control The Journal of infectious diseases 2017 [PMID: 28968755]
  64. de Sanjosé S, Brotons M, Pavón MA. The natural history of human papillomavirus infection Best practice & research. Clinical obstetrics & gynaecology 2017 [PMID: 28964706]
  65. Ning T, Wolfe A, Nie J, Huang W, Chen XS, Wang Y. Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization The Journal of infectious diseases 2017 [PMID: 28968823]
  66. Ake JA, Schuetz A, Pegu P, Wieczorek L, Eller MA, Kibuuka H, Sawe F, Maboko L, Polonis V, Karasavva N, Weiner D, Sekiziyivu A, Kosgei J, Missanga M, Kroidl A, Mann P, Ratto-Kim S, Eller LA, Earl P, Moss B, Dorsey-Spitz J, Milazzo M, Ouedraogo GL, Rizvi F, Yan J, Khan AS, Peel S, Sardesai NY, Michael NL, Ngauy V, Marovich M, Robb ML. Safety and Immunogenicity of PENNVAX®-G DNA Prime Administered by Biojector® 2000 or CELLECTRA® Electroporation Device with Modified Vaccinia Ankara-CMDR Boost The Journal of infectious diseases 2017 [PMID: 28968759]
  67. Fong Y, Huang Y, Lemos MP, Mcelrath MJ. Rank-based two-sample tests for paired data with missing values Biostatistics (Oxford, England) 2017 [PMID: 28968816]
  68. Kuguyo O, Matimba A, Tsikai N, Magwali T, Madziyire M, Gidiri M, Dandara C, Nhachi C. Cervical cancer in Zimbabwe: a situation analysis The Pan African medical journal 27:215 2017 [PMID: 28979617]
  69. Sun Y, Qiao Y, Zhu Y, Chong H, He Y. Identification of a novel HIV-1-neutralizing antibody from a CRF07_BC-infected Chinese donor Oncotarget 8(38):63047-63063 2017 [PMID: 28968970]
  70. Wang N, Yuan Z, Niu W, Li Q, Guo J. Synthetic biology approach for the development of conditionally replicating HIV-1 vaccine Journal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986) 92(3):455-462 2017 [PMID: 28983143]
  71. Wanyenze RK, Bwanika JB, Beyeza-Kashesya J, Mugerwa S, Arinaitwe J, Matovu JKB, Gwokyalya V, Kasozi D, Bukenya J, Makumbi F. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda Global health action 10(1):1380361 2017 [PMID: 29035163]
  72. Nomura W. Creation of Functional Molecules Based on Biomolecular Interactions; Development toward Chemical Biology Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 137(10):1223-1231 2017 [PMID: 28966263]

Lassa virus

  1. Gonzalez-Quintial R, Baccala R. Murine Models for Viral Hemorrhagic Fever Methods in molecular biology (Clifton, N.J.) 1604:257-267 2018 [PMID: 28986841]
  2. Qi X, Wang W, Dong H, Liang Y, Dong C, Ly H. Expression and X-Ray Structural Determination of the Nucleoprotein of Lassa Fever Virus Methods in molecular biology (Clifton, N.J.) 1604:179-188 2018 [PMID: 28986833]
  3. Salvato MS, Lukashevich IS, Medina-Moreno S, Zapata JC. Diagnostics for Lassa Fever: Detecting Host Antibody Responses Methods in molecular biology (Clifton, N.J.) 1604:79-88 2018 [PMID: 28986826]
  4. Galan-Navarro C, Rincon-Restrepo M, Zimmer G, Ollmann Saphire E, Hubbell JA, Hirosue S, Swartz MA, Kunz S. Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein Virology 512:161-171 2017 [PMID: 28963882]

Marburg virus

  1. Schafer AM, Cheng H, Lee C, Du R, Han J, Perez J, Peet N, Manicassamy B, Rong L. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Current medicinal chemistry 2017 [PMID: 29032747]
  2. Agnandji ST, Fernandes JF, Bache EB, Obiang Mba RM, Brosnahan JS, Kabwende L, Pitzinger P, Staarink P, Massinga-Loembe M, Krähling V, Biedenkopf N, Fehling SK, Strecker T, Clark DJ, Staines HM, Hooper JW, Silvera P, Moorthy V, Kieny MP, Adegnika AA, Grobusch MP, Becker S, Ramharter M, Mordmüller B, Lell B, Krishna S, Kremsner PG. Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial PLoS medicine 14(10):e1002402 2017 [PMID: 28985239]
  3. Cossarizza A, Chang HD, Radbruch A, Andrä I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, Baumgart S, Becher B, Beisker W, Berek C, Blanco A, Borsellino G, Boulais PE, Brinkman RR, Büscher M, Busch DH, Bushnell TP, Cao X, Cavani A, Chattopadhyay PK, Cheng Q, Chow S, Clerici M, Cooke A, Cosma A, Cosmi L, Cumano A, Dang VD, Davies D, De Biasi S, Del Zotto G, Della Bella S, Dellabona P, Deniz G, Dessing M, Diefenbach A, Di Santo J, Dieli F, Dolf A, Donnenberg VS, Dörner T, Ehrhardt GRA, Endl E, Engel P, Engelhardt B, Esser C, Everts B, Falk CS, Fehniger TA, Filby A, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frenette PS, Galbraith D, Garbi N, García-Godoy MD, Ghoreschi K, Gibellini L, Goettlinger C, Goodyear CS, Gori A, Grogan J, Gross M, Grützkau A, Grummitt D, Hahn J, Hammer Q, Hauser AE, Haviland DL, Hedley D, Herrera G, Herrmann M, Hiepe F, Holland T, Hombrink P, Houston JP, Hoyer BF, Huang B, Hunter CA, Iannone A, Jäck HM, Jávega B, Jonjic S, Juelke K, Jung S, Kaiser T, Kalina T, Keller B, Khan S, Kienhöfer D, Kroneis T, Kunkel D, Kurts C, Kvistborg P, Lannigan J, Lantz O, Larbi A, LeibundGut-Landmann S, Leipold MD, Levings MK, Litwin V, Liu Y, Lohoff M, Lombardi G, Lopez L, Lovett-Racke A, Lubberts E, Ludewig B, Lugli E, Maecker HT, Martrus G, Matarese G, Maueröder C, McGrath M, McInnes I, Mei HE, Melchers F, Melzer S, Mielenz D, Mills K, Mjösberg J, Moore J, Moran B, Moretta A, Moretta L, Mosmann TR, Müller S, Müller W, Münz C, Multhoff G, Munoz LE, Murphy KM, Nakayama T, Nasi M, Neudörfl C, Nolan J, Nourshargh S, O'Connor JE, Ouyang W, Oxenius A, Palankar R, Panse I, Peterson P, Peth C, Petriz J, Philips D, Pickl W, Piconese S, Pinti M, Pockley AG, Podolska MJ, Pucillo C, Quataert SA, Radstake TRDJ, Rajwa B, Rebhahn JA, Recktenwald D, Remmerswaal EBM, Rezvani K, Rico LG, Robinson JP, Romagnani C, Rubartelli A, Ruland J, Sakaguchi S, Sala-de-Oyanguren F, Samstag Y, Sanderson S, Sawitzki B, Scheffold A, Schiemann M, Schildberg F, Schimisky E, Schmid SA, Schmitt S, Schober K, Schüler T, Schulz AR, Schumacher T, Scotta C, Shankey TV, Shemer A, Simon AK, Spidlen J, Stall AM, Stark R, Stehle C, Stein M, Steinmetz T, Stockinger H, Takahama Y, Tarnok A, Tian Z, Toldi G, Tornack J, Traggiai E, Trotter J, Ulrich H, van der Braber M, van Lier RAW, Veldhoen M, Vento-Asturias S, Vieira P, Voehringer D, Volk HD, von Volkmann K, Waisman A, Walker R, Ward MD, Warnatz K, Warth S, Watson JV, Watzl C, Wegener L, Wiedemann A, Wienands J, Willimsky G, Wing J, Wurst P, Yu L, Yue A, Zhang Q, Zhao Y, Ziegler S, Zimmermann J. Guidelines for the use of flow cytometry and cell sorting in immunological studies European journal of immunology 47(10):1584-1797 2017 [PMID: 29023707]

Mycobacterium tuberculosis (tuberculosis)

  1. Adu-Gyamfi CG, Snyman T, Hoffmann CJ, Martinson NA, Chaisson RE, George JA, Suchard MS. Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 65(8):1356-1358 2017 [PMID: 29017244]
  2. Saifullah B, Chrzastek A, Maitra A, Naeemullah B, Fakurazi S, Bhakta S, Hussein MZ. Novel Anti-Tuberculosis Nanodelivery Formulation of Ethambutol with Graphene Oxide Molecules (Basel, Switzerland) 22(10) 2017 [PMID: 29023399]
  3. Saifullah B, Maitra A, Chrzastek A, Naeemullah B, Fakurazi S, Bhakta S, Hussein MZ. Nano-Formulation of Ethambutol with Multifunctional Graphene Oxide and Magnetic Nanoparticles Retains Its Anti-Tubercular Activity with Prospects of Improving Chemotherapeutic Efficacy Molecules (Basel, Switzerland) 22(10) 2017 [PMID: 29023384]
  4. Hatipoglu N, Güvenç BH, Deswarte C, Koksalan K, Boisson-Dupuis S, Casanova JL, Bustamante J. Inherited IL-12Rβ1 Deficiency in a Child With BCG Adenitis and Oral Candidiasis: A Case Report Pediatrics 2017 [PMID: 29025965]
  5. Buzdugan SN, Chambers MA, Delahay RJ, Drewe JA. Quantitative interferon-gamma responses predict future disease progression in badgers naturally infected with Mycobacterium bovis Epidemiology and infection :1-10 2017 [PMID: 29017616]
  6. Gong W, Xiong X, Wang P, Jiao J, Yang X, Wen B. Th1 epitope peptides induce protective immunity against Rickettsia rickettsii infection in C3H/HeN mice Vaccine 2017 [PMID: 29032899]
  7. Deep A, Kaundal S, Agarwal S, Singh R, Thakur KG. Crystal structure of Mycobacterium tuberculosis VapC20 toxin and its interactions with cognate antitoxin, VapB20, suggest a model for toxin-antitoxin assembly The FEBS journal 2017 [PMID: 28986943]
  8. Jee B, Kumar S, Yadav R, Singh Y, Kumar A, Sharma N. Ursolic acid and carvacrol may be potential inhibitors of dormancy protein small heat shock protein16.3 of Mycobacterium tuberculosis Journal of biomolecular structure & dynamics :1-29 2017 [PMID: 28984500]
  9. Rai PK, Chodisetti SB, Zeng W, Nadeem S, Maurya SK, Pahari S, Janmeja AK, Jackson DC, Agrewala JN. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity Journal of translational medicine 15(1):201 2017 [PMID: 28985739]
  10. Beg S, Gaur P, Mishra S. New Drugs And Vaccines For Tuberculosis Recent patents on anti-infective drug discovery 2017 [PMID: 28990539]
  11. Ullah Z, Athar MT, Samad A. Nanomedicine for the Treatment of Tuberculosis Recent patents on anti-infective drug discovery 2017 [PMID: 28990537]
  12. Shin HJ, Franco LH, Nair VR, Collins AC, Shiloh MU. A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan PloS one 12(10):e0185945 2017 [PMID: 28982200]
  13. Lyashchenko KP, Grandison A, Keskinen K, Sikar-Gang A, Lambotte P, Esfandiari J, Ireton GC, Vallur A, Reed SG, Jones G, Vordermeier HM, Stabel JR, Thacker TC, Palmer MV, Waters WR. Identification of novel antigens recognized by serum antibodies in bovine tuberculosis Clinical and vaccine immunology : CVI 2017 [PMID: 28978510]
  14. Kheir AEM, Ibrahim SA, Abdelsatir A, Bahar ME. Osteitis of the radius following Bacillus Calmette-Guérin vaccination at birth: a case report Journal of medical case reports 11(1):283 2017 [PMID: 28974253]
  15. Thompson H, Thakur K. Infections of the Central Nervous System in Returning Travelers and Immigrants Current infectious disease reports 19(11):45 2017 [PMID: 28975470]
  16. Speth MT, Repnik U, Müller E, Spanier J, Kalinke U, Corthay A, Griffiths G. Poly(I:C)-encapsulating nanoparticles enhance innate immune responses to the tuberculosis vaccine Bacille-Calmette-Guérin (BCG) via synergistic activation of innate immune receptors Molecular pharmaceutics 2017 [PMID: 28974092]
  17. Otsuka T, Hosokai R, Watanabe T, Ishiwada N, Saitoh A. Subcutaneous chest wall abscess as a complication of BCG vaccination Pediatrics international : official journal of the Japan Pediatric Society 2017 [PMID: 28972299]
  18. Yin Y, Lian K, Zhao D, Tao C, Chen X, Tan W, Wang X, Xu Z, Hu M, Rao Y, Zhou X, Pan Z, Zhang X, Jiao X. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis Frontiers in cellular and infection microbiology 7:407 2017 [PMID: 29034213]
  19. Nemes E, Hesseling AC, Tameris M, Mauff K, Downing K, Mulenga H, Rose P, van der Zalm M, Mbaba S, Van As D, Hanekom WA, Walzl G, Scriba TJ, McShane H, Hatherill M. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 [PMID: 29028973]
  20. Hu S, Yu W, Hu C, Wei D, Shen L, Hu T, Yi Y. Conjugation of the CRM<sub>197</sub>-inulin conjugate significantly increases the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein Bioorganic & medicinal chemistry 2017 [PMID: 28967465]
  21. Nieuwenhuizen NE, Kulkarni PS, Shaligram U, Cotton MF, Rentsch CA, Eisele B, Grode L, Kaufmann SHE. The Recombinant Bacille Calmette-Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing Frontiers in immunology 8:1147 2017 [PMID: 28974949]
  22. De A, Sarkar S, Sharma N, Ansari A, Reja AHH, Sarda A. BCG-induced Disseminated Mycobacterial Infection of Skin and Bone in an Otherwise Immunocompetent Child Indian journal of dermatology 62(5):519-523 2017 [PMID: 28979017]
  23. Mangtani P, Nguipdop-Djomo P, Keogh RH, Sterne JAC, Abubakar I, Smith PG, Fine PEM, Vynnycky E, Watson JM, Elliman D, Lipman M, Rodrigues LC. The duration of protection of school-aged BCG vaccination in England: a population -based case-control study International journal of epidemiology 2017 [PMID: 29025083]
  24. Martinez L, Shen Y, Mupere E, Kizza A, Hill PC, Whalen CC. Transmission of Mycobacterium Tuberculosis in Households and the Community: A Systematic Review and Meta-Analysis American journal of epidemiology 185(12):1327-1339 2017 [PMID: 28982226]
  25. Hsairi M, Ben Braham M, Gamara D, Fourati R, Abid F, Tritar F, Charfi MR. Tuberculosis cost in tunisia La Tunisie medicale 94(10):604-611 2016 [PMID: 28972252]

Plasmodium falciparum (Malaria)

  1. Andersson ME, Elfving K, Shakely D, Nilsson S, Msellem M, Trollfors B, Mårtensson A, Björkman A, Lindh M. Rapid Clearance and Frequent Reinfection With Enteric Pathogens Among Children With Acute Diarrhea in Zanzibar Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 65(8):1371-1377 2017 [PMID: 29017253]
  2. Parzych EM, Miura K, Ramanathan A, Long CA, Burns JM Jr. Evaluation of a <i>Plasmodium</i>-specific carrier protein to enhance production of recombinant <i>Pf</i>s25, a leading transmission-blocking vaccine candidate Infection and immunity 2017 [PMID: 28993460]
  3. Doritchamou J, Teo A, Fried M, Duffy PE. Malaria in pregnancy: the relevance of animal models for vaccine development Lab animal 46(10):388-398 2017 [PMID: 28984865]
  4. Hussein HE, Bastos RG, Schneider DA, Johnson WC, Adham FK, Davis WC, Laughery JM, Herndon DR, Alzan HF, Ueti MW, Suarez CE. The Babesia bovis hap2 gene is not required for blood stage replication, but expressed upon in vitro sexual stage induction PLoS neglected tropical diseases 11(10):e0005965 2017 [PMID: 28985216]
  5. Alampalli S, Grover M, Chandran S, Tatu U, Achary P. Proteome and Structural Organization of the Knob Complex on the Surface of the Plasmodium Infected Red Blood Cell Proteomics. Clinical applications 2017 [PMID: 28981210]
  6. Thériault C, Richard D. Characterization of a putative Plasmodium falciparum SAC1 phosphoinositide-phosphatase homologue potentially required for survival during the asexual erythrocytic stages Scientific reports 7(1):12710 2017 [PMID: 28983103]
  7. Iyori M, Yamamoto DS, Sakaguchi M, Mizutani M, Ogata S, Nishiura H, Tamura T, Matsuoka H, Yoshida S. DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice Malaria journal 16(1):390 2017 [PMID: 28962615]
  8. Cunha JA, Carvalho LJM, Bianco-Junior C, Andrade MCR, Pratt-Riccio LR, Riccio EKP, Pelajo-Machado M, da Silva IJ, Druilhe P, Daniel-Ribeiro CT. Increased <i>Plasmodium falciparum</i> Parasitemia in Non-splenectomized <i>Saimiri sciureus</i> Monkeys Treated with Clodronate Liposomes Frontiers in cellular and infection microbiology 7:408 2017 [PMID: 28983468]
  9. Pratt-Riccio LR, De Souza Perce-Da-Silva D, Da Costa Lima-Junior J, Pratt Riccio EK, Ribeiro-Alves M, Santos F, Arruda M, Camus D, Druilhe P, Oliveira-Ferreira J, Daniel-Ribeiro CT, Banic DM. Synthetic Antigens Derived from <i>Plasmodium falciparum</i> Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area The American journal of tropical medicine and hygiene 2017 [PMID: 29016339]
  10. Nyboer B, Heiss K, Mueller AK, Ingmundson A. The Plasmodium liver-stage parasitophorous vacuole: A front-line of communication between parasite and host International journal of medical microbiology : IJMM 2017 [PMID: 28964681]
  11. Thwing J, Eckert E, Dione DA, Tine R, Faye A, Yé Y, Ndiop M, Cisse M, Ndione JA, Diouf MB, Ba M. Declines in Malaria Burden and All-Cause Child Mortality following Increases in Control Interventions in Senegal, 2005-2010 The American journal of tropical medicine and hygiene 97(3_Suppl):89-98 2017 [PMID: 28990913]
  12. Essuman E, Grabias B, Verma N, Chorazeczewski JK, Tripathi AK, Mlambo G, Addison EA, Amoah AGB, Quakyi I, Oakley MS, Kumar S. A Novel Gametocyte Biomarker for Superior Molecular Detection of the Plasmodium falciparum Infectious Reservoirs The Journal of infectious diseases 2017 [PMID: 28968664]
  13. Mugyenyi CK, Elliott SR, Yap XZ, Feng G, Boeuf P, Fegan G, Osier FFH, Fowkes FJI, Avril M, Williams TN, Marsh K, Beeson JG. Declining malaria transmission differentially impacts on the maintenance of humoral immunity to Plasmodium falciparum in children The Journal of infectious diseases 2017 [PMID: 28973483]

Salmonella

  1. Methner U, Berndt A, Locke M. Salmonella Enteritidis with double deletion in phoP fliC and a competitive exclusion culture elicit substantial additive protective effects against Salmonella exposure in newly hatched chicks Vaccine 35(45):6076-6082 2017 [PMID: 28987440]
  2. Taylor M, Cox W, Otterstatter M, de With N, Galanis E. Evaluation of Agricultural Interventions on Human and Poultry-Related Salmonella Enteritidis in British Columbia Foodborne pathogens and disease 2017 [PMID: 29028435]
  3. Ding K, Shang K, Yu ZH, Yu C, Jia YY, He L, Liao CS, Li J, Zhang CJ, Li YJ, Wu TC, Cheng XC. Recombinant-attenuated Salmonella pullorum strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge Journal of veterinary science 2017 [PMID: 29032660]
  4. Hatipoglu N, Güvenç BH, Deswarte C, Koksalan K, Boisson-Dupuis S, Casanova JL, Bustamante J. Inherited IL-12Rβ1 Deficiency in a Child With BCG Adenitis and Oral Candidiasis: A Case Report Pediatrics 2017 [PMID: 29025965]
  5. Howlader DR, Koley H, Maiti S, Bhaumik U, Mukherjee P, Dutta S. A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever Vaccine 2017 [PMID: 29031693]
  6. Smith RP, Andres V, Martelli F, Gosling B, Marco-Jimenez F, Vaughan K, Tchorzewska M, Davies R. Maternal vaccination as a Salmonella Typhimurium reduction strategy on pig farms Journal of applied microbiology 2017 [PMID: 29024207]
  7. Mett V, Komarova EA, Greene K, Bespalov I, Brackett C, Gillard B, Gleiberman AS, Toshkov IA, Aygün-Sunar S, Johnson C, Karasik E, Bapardekar-Nair M, Kurnasov OV, Osterman AL, Stanhope-Baker PS, Morrison C, Moser MT, Foster BA, Gudkov AV. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy Oncogene 2017 [PMID: 28967901]
  8. Smith AM, Smouse SL, Tau NP, Bamford C, Moodley VM, Jacobs C, McCarthy KM, Lourens A, Keddy KH. Laboratory-acquired infections of Salmonella enterica serotype Typhi in South Africa: phenotypic and genotypic analysis of isolates BMC infectious diseases 17(1):656 2017 [PMID: 28962627]
  9. Jin C, Gibani MM, Moore M, Juel HB, Jones E, Meiring J, Harris V, Gardner J, Nebykova A, Kerridge SA, Hill J, Thomaides-Brears H, Blohmke CJ, Yu LM, Angus B, Pollard AJ. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial Lancet (London, England) 2017 [PMID: 28965718]
  10. Darton TC, Baker S, Randall A, Dongol S, Karkey A, Voysey M, Carter MJ, Jones C, Trappl K, Pablo J, Hung C, Teng A, Shandling A, Le T, Walker C, Molina D, Andrews J, Arjyal A, Basnyat B, Pollard AJ, Blohmke CJ. Identification of Novel Serodiagnostic Signatures of Typhoid Fever Using a <i>Salmonella</i> Proteome Array Frontiers in microbiology 8:1794 2017 [PMID: 28970824]
  11. Booth JS, Patil SA, Ghazi L, Barnes R, Fraser CM, Fasano A, Greenwald BD, Sztein MB. Systemic and Terminal Ileum Mucosal Immunity Elicited by Oral Immunization With the Ty21a Typhoid Vaccine in Humans Cellular and molecular gastroenterology and hepatology 4(3):419-437 2017 [PMID: 29022005]
  12. Yu C, Zhai C, Liao C, Yu Z, He L, Jia Y, Li J, Zhang C, Cheng X. [Construction and characterization of type III secretion system of attenuated Salmonella typhimurium] Sheng wu gong cheng xue bao = Chinese journal of biotechnology 32(12):1664-1675 2016 [PMID: 29034634]

Shigella

  1. Andersson ME, Elfving K, Shakely D, Nilsson S, Msellem M, Trollfors B, Mårtensson A, Björkman A, Lindh M. Rapid Clearance and Frequent Reinfection With Enteric Pathogens Among Children With Acute Diarrhea in Zanzibar Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 65(8):1371-1377 2017 [PMID: 29017253]
  2. Hosangadi D, Smith PG, Giersing BK. Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy Vaccine 2017 [PMID: 29031690]
  3. Walker RI, Wierzba TF, Mani S, Bourgeois AL. Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference Vaccine 2017 [PMID: 28987444]

Variola major (Smallpox)

  1. Schrick L, Tausch SH, Dabrowski PW, Damaso CR, Esparza J, Nitsche A. An Early American Smallpox Vaccine Based on Horsepox The New England journal of medicine 377(15):1491-1492 2017 [PMID: 29020595]
  2. Townsend MB, Gallardo-Romero NF, Khmaladze E, Vora NM, Maghlakelidze G, Geleishvili M, Carroll DS, Emerson GL, Reynolds MG, Satheshkumar PS. Retrospective proteomic analysis of serum after Akhmeta virus infection: new suspect case identification and insights into poxvirus humoral immunity The Journal of infectious diseases 2017 [PMID: 29029254]

Vibrio cholerae

  1. Sow SO, Tapia MD, Chen WH, Haidara FC, Kotloff KL, Pasetti MF, Blackwelder WC, Traoré A, Tamboura B, Doumbia M, Diallo F, Coulibaly F, Onwuchekwa U, Kodio M, Tennant SM, Reymann M, Lam DF, Gurwith M, Lock M, Yonker T, Smith J, Simon JK, Levine MM. A randomized, placebo-controlled, double-blind Phase 2 trial comparing the reactogenicity and immunogenicity of a single ≥2x10<sup>8</sup> colony forming units [cfu] standard-dose versus a ≥2x10<sup>9</sup> cfu high-dose of CVD 103-HgR live attenuated oral cholera vaccine, with Shanchol inactivated oral vaccine as an open label immunologic comparator Clinical and vaccine immunology : CVI 2017 [PMID: 29021299]
  2. Semá Baltazar C, Langa JP, Dengo Baloi L, Wood R, Ouedraogo I, Njanpop-Lafourcade BM, Inguane D, Elias Chitio J, Mhlanga T, Gujral L, D Gessner B, Munier A, A Mengel M. Multi-site cholera surveillance within the African Cholera Surveillance Network shows endemicity in Mozambique, 2011-2015 PLoS neglected tropical diseases 11(10):e0005941 2017 [PMID: 28991895]
  3. Mosley JF 2nd, Smith LL, Brantley P, Locke D, Como M. Vaxchora: The First FDA-Approved Cholera Vaccination in the United States P & T : a peer-reviewed journal for formulary management 42(10):638-640 2017 [PMID: 29018300]

Yersinia pestis (Plague)

  1. Leal EA, Moreira JD, Nunes FF, Souza LR, Martins JM, Toledo VPC, Almeida AMP, Guimarães TMP. Humoral and cellular immune response of mice challenged with Yersinia pestis antigenic preparations The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2017 [PMID: 29031042]

Click HERE to see the publications in the last month.